Related Experiment Video
Updated: Apr 8, 2026
11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
2.0K
Summary
Researchers report a novel immunotherapy approach for Hodgkin lymphoma (HL) using a bispecific antibody. This phase 1 study of AFM13 shows a new principle for targeted HL treatment.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Hodgkin lymphoma (HL) is a cancer of the lymphatic system.
- Current HL treatments include chemotherapy and radiation, but novel targeted therapies are needed.
Purpose of the Study:
- To evaluate the safety and efficacy of a new bispecific antibody, AFM13, for Hodgkin lymphoma treatment.
- To introduce a new principle of targeted immunotherapy for HL.
Main Methods:
- Phase 1 clinical study.
- Administration of the bispecific anti-CD30/CD16A antibody construct AFM13.
- Evaluation of safety, tolerability, and preliminary efficacy.
Main Results:
- AFM13 demonstrated a new principle of targeted immunotherapy for HL.
- Preliminary data suggests potential efficacy and acceptable safety profile.
Conclusions:
- AFM13 represents a promising new therapeutic strategy for Hodgkin lymphoma.
- Further investigation in larger trials is warranted to confirm these findings.
Related Concept Videos
01:27Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.8K
1.8K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K